Emre Can Polat

Emre Can Polat

Auto-generated profile, based on publicly available information

Emre Can Polat

Department of Urology, Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Renal Failure
Verified
Journal Article
Closed access
EOEmin Ozbek
Emin Ozbek
MCMustafa Cekmen
Mustafa Cekmen
YIYusuf Ozlem Ilbey
Yusuf Ozlem Ilbey
ASAbdulmuttalip Simsek
Abdulmuttalip Simsek
EPEmre Can Polat
Emre Can Polat
ASAdnan Somay
Adnan Somay
Gentamicin (GM) is still considered to be an important antibiotic against life-threatening, gram-negative bacterial infections despite its known nephrotoxic effects. We aimed to evaluate the potential protective effect of atorvastatin (ATO) against GM-induced nephrotoxicity in rats. The rats were randomly divided into five groups of six animals each: control, GM (100 mg/kg/day), ATO (10 mg/kg/day), GM + ATO, and GM + Vehicle. Kidney function tests, tissue oxidative stress parameters, and histopathological and immunohistochemical studies clarified GM nephrotoxicity. GM caused a marked reduction in renal functions and increased oxidative stress parameters. Histopathological examination revealed tubular necrosis especially in the renal cortex in GM rats. On immunohistochemical evaluation, GM rat showed more intense expressions of mitogen-activated protein kinase (MAPK), nuclear factor kappa B (NF-kappaB), and inducible nitric oxide synthase (iNOS) compared with control. Kidney function tests and tissue oxidative stress parameters were normalized in the GM + ATO group. Histopathological and immunohistochemical pictures were also greatly ameliorated. ATO acts in the kidney as a potent scavenger of free radicals to prevent the toxic effects of GM via the inhibition of MAPK and NF-kappaB signaling pathways and iNOS expression.

2 March 2009 in Asian Journal of Andrology
Verified
Journal Article
Open access
EOEmin Ozbek
Emin Ozbek
ATAli I Tasci
Ali I Tasci
VTVolkan Tugcu
Volkan Tugcu
YIYusuf O Ilbey
Yusuf O Ilbey
ASAbdulmuttalip Simsek
Abdulmuttalip Simsek
VKVedat Koksal
Vedat Koksal
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.

1 July 2012 in Journal of Endourology
Verified
Journal Article
Closed access
ATAbdulkadir Tepeler
Abdulkadir Tepeler
AAAbdullah Armağan
Abdullah Armağan
TATolga Akman
Tolga Akman
EPEmre Can Polat
Emre Can Polat
CECevper Ersöz
Cevper Ersöz
ŞÖŞinasi Yavuz Önol
Şinasi Yavuz Önol
Background and Purpose: Percutaneous nephrolithotomy (PCNL) is regarded as the gold standard for the treatment of patients with renal stones larger than 2 cm in diameter. Creating a percutaneous renal access is the initial and probably the most important step in performing a PCNL. Two primary methods of obtaining proper percutaneous renal access under fluoroscopic guidance are described: The “triangulation” and the “eye of the needle” techniques. In this article, we compare these two techniques in terms of success and complication rates. Patients and Methods: From October 2010 to May 2011, 80 patients with simple renal stones were prospectively randomized into two groups according to the percutaneous renal access technique used for PCNL. Patients in group 1 (n=40) were assigned to the eye of the needle technique, and patients in group 2 (n=40) were assigned to the triangulation method. Patients needing multiple access points were excluded from the study. The preoperative, operative, and postoperative follow-up findings were thereafter analyzed and compared. Results: No significant difference between the two groups was detected in terms of patient demographics (mean patient age, body mass index, stone size, or stone location). The operation time, fluoroscopic screening time (FST), and duration of hospitalization were similar in both groups (P=0.52, P=0.32, P=0.26, respectively). Patients in group 1 had a larger drop in hematocrit postoperatively than patients in group 2 (7.6±3.7 vs 4.8±2.1, P=0.001). The blood transfusion rate (7.5%) was similar in both groups, however. Although the complication rate was higher in group 1 than group 2, no significant difference was detected (20% vs 15%, P=0.76). Conclusions: The present study demonstrates that PCNL can be performed safely using two different percutaneous access techniques. The two techniques studied in this trial had similar FSTs, operation and hospitalization times, success rates, and complication rates.

24 January 2013 in Renal Failure
Verified
Journal Article
Closed access
PDF file
AOAlper Otunctemur
Alper Otunctemur
EOEmin Ozbek
Emin Ozbek
MCMustafa Cekmen
Mustafa Cekmen
SCSuleyman Sami Cakir
Suleyman Sami Cakir
MDMurat Dursun
Murat Dursun
NONurver Ozbay
Nurver Ozbay
Nephrotoxicity is a major complication of gentamicin (GEN). We aimed to evaluate the potential protective effect of montelukast (MK) against GEN-induced nephrotoxicity in rats. Thirty-two rats were randomly divided into four groups, each consisting of eight animals as follows: (1) the rats were control; (2) intraperitoneally injected with GEN 14 consecutive days (100 mg/kg/day); (3) treated with GEN plus distilled water via nasogastric gavage for 14 days; and (4) treated with GEN plus MK (10 mg/kg/day) for 14 days. After 15 days, rats were killed and their kidneys were taken and blood analysis was performed. Twenty-four hours urine collections were obtained in standard metabolic cages a day before the rats were killed. Tubular necrosis and interstitial fibrosis scoring were determined histopathologically in a part of kidneys; nitric oxide (NO), malondialdehyde (MDA), and reduced glutathione (GSH) levels were determined in the other part of kidneys. Statistical analyses were made by the chi-square test and analysis of variance. Serum urea and creatinine levels were significantly higher in rats treated with GEN alone, than the rats in control and GEN + MK groups.The GSH levels in renal tissue of only GEN-treated rats were significantly lower than those in control group, and administration of MK to GEN-treated rats significantly increased the level of GSH. The group that was given GEN and MK had significantly lower MDA and NO levels in kidney cortex tissue than those that was given GEN alone. In rats treated with GEN + MK, despite the presence of mild tubular degeneration and tubular necrosis are less severe, and glomeruli maintained a better morphology when compared with GEN group. We can say that MK prevents kidney damage with antioxidant effect, independently of NO.

22 March 2011 in American Journal of Nephrology
Verified
Journal Article
Closed access
DTDilek Telci
Dilek Telci
ADAli Umman Dogan
Ali Umman Dogan
EOEmin Ozbek
Emin Ozbek
EPEmre Can Polat
Emre Can Polat
ASAbdulmuttalip Simsek
Abdulmuttalip Simsek
FSFikrettin Sahin
Fikrettin Sahin
Background/Aims: KLOTHO, a type-1 transmembrane protein with glucurodinase activity, is expressed in tissues responsible for calcium homeostasis such as the kidney, parathyroid gland and the epithelium of the choroid plexus in the brain. Given the emerging evidence indicating a novel regulatory function for KLOTHO protein in renal calcium and phosphate homeostasis, the present study aims to investigate the association between KLOTHO genetic polymorphisms and kidney stone (KS). Methods:KLOTHO gene polymorphisms G395A in the promoter region, F252V in exon 2, and C1818T in exon 4 were investigated in 108 patients with renal calcium stone formation and 51 age-matched healthy volunteers with no history of renal stone formation, using polymerase chain reaction. Results: GG genotype of G395A KLOTHO polymorphism had approximately 2-fold increased KS risk compared with the homozygous genotype AA and heterozygote GA (OR 1.849, 95% CI 1.016–3.364, p = 0.044). We also found that non-A allele carriers had significantly higher KS risk associated with the KS clinical characteristics including hypercalcemia, hypophosphatemia and phosphaturia. Conclusion: Our findings suggested that the G395A polymorphism of KLOTHO gene is associated with the KSs and may act as a risk factor for the development of KS disease.

11 June 2014 in Journal of Sex & Marital Therapy
Verified
Journal Article
Closed access
AOAlper Otunctemur
Alper Otunctemur
MDMurat Dursun
Murat Dursun
EOEmin Ozbek
Emin Ozbek
SSSuleyman Sahin
Suleyman Sahin
HBHuseyin Besiroglu
Huseyin Besiroglu
MBMuammer Bozkurt
Muammer Bozkurt
Female sexual dysfunction is a prevalent and multidimensional disorder related to many biological, psychological, and social determinants. The authors assessed the effect of one of the many factors affect sexual function-metabolic syndrome-on female sexual function. They equally divided 400 women participants among 4 groups: (a) premenopausal with metabolic syndrome, (b) premenopausal without metabolic syndrome, (c) postmenopausal with metabolic syndrome, and (d) postmenopausal without metabolic syndrome. The authors used the Female Sexual Function Index to assess women's sexual function. Female sexual dysfunction was found more often in both pre- and postmenopausal women with metabolic syndrome (p =.001). Overall Female Sexual Function Index score and satisfaction, pain, and desire domain scores independently of the menopause status showed statistically significant differences across women with metabolic syndrome in comparison with participants with no metabolic syndrome (p <.05). The authors also evaluated the associations among 5 components of metabolic syndrome and Female Sexual Function Index scores. Higher fasting glucose levels were significantly associated with the Female Sexual Function Index score (p <.05). This study shows that sexual dysfunction is more prevalent in pre- and postmenopausal women with the metabolic syndrome.